The Discussion and Literature Review on One Copy of Electrocardiogram in the Diagnosis of Heart Failure

2019 ◽  
Vol 07 (02) ◽  
pp. 41-46
Author(s):  
卫滨 贾
Keyword(s):  
Heart Failure ◽  
Literature Review

scholarly journals Evaluating risk prediction models for adults with heart failure: A systematic literature review

PLoS ONE ◽  
2020 ◽  
Vol 15 (1) ◽  
pp. e0224135 ◽  
Author(s):  
Gian Luca Di Tanna ◽  
Heidi Wirtz ◽  
Karen L. Burrows ◽  
Gary Globe
Keyword(s):  
Heart Failure ◽  
Literature Review ◽  
Risk Prediction ◽  
Systematic Literature Review ◽  
Prediction Models ◽  
Risk Prediction Models

Prevalence of heart failure in nursing homes: a systematic literature review

2010 ◽  
Vol 24 (1) ◽  
pp. 202-208 ◽  
Author(s):  
Mariëlle A. M. J. Daamen ◽  
Jos M. G. A. Schols ◽  
Tiny Jaarsma ◽  
Jan P. H. Hamers
Keyword(s):  
Heart Failure ◽  
Nursing Homes ◽  
Literature Review ◽  
Systematic Literature Review

scholarly journals Biomarcadores Cardíacos como preditores do prognóstico na Insuficiência Cardíaca: uma Revisão Sistemática da Literatura / Cardiac Biomarkers as Predictors of Prognosis in Heart Failure: A Systematic Literature Review

2021 ◽  
Vol 4 (5) ◽  
pp. 22389-22402
Author(s):  
Noelia Gonçalves Dos Santos ◽  
Isadora dos Santos Lima ◽  
Lenise Costa De Carvalho ◽  
Diego Cézar Guirra Freitas Andrade ◽  
Mariana de Freitas Rocha ◽  
...  
Keyword(s):  
Heart Failure ◽  
Literature Review ◽  
Systematic Literature Review ◽  
Cardiac Biomarkers ◽  
Insuficiencia Cardiaca

scholarly journals Concurrent End-Stage Cardiomyopathy and Aortic Disease in Patients with Marfan Syndrome: A Case Report and Literature Review

2021 ◽  
Author(s):  
Timothy Smith ◽  
Jose Sleiman ◽  
Nikita Zadneulitca ◽  
Cedric Sheffield ◽  
Viviana Navas ◽  
...  
Keyword(s):  
Heart Failure ◽  
Case Report ◽  
Literature Review ◽  
Marfan Syndrome ◽  
Aortic Disease ◽  
Connective Tissue Disorder ◽  
Orthotopic Heart Transplantation ◽  
Bentall Procedure ◽  
Life Saving ◽  
End Stage

Abstract Background: Marfan syndrome (MFS) is a connective tissue disorder that can lead to aortic disease, arrhythmias and heart failure. Many centers are reluctant to offer orthotopic heart transplantation (OHT) for patients with MFS with concurrent aortic disease due to complexity of the surgery and perceived inferior results when compared to patients without MFS. Methods: We present a case of a patient with MFS with previous Bentall procedure who underwent successful OHT, accompanied by a literature review on OHT performed for patients with MFS. Results and Conclusions: Patients with MFS who underwent OHT had no difference in mortality compared to patients without MFS. Even though OHT is technically more challenging when combined with concurrent intervention for aortic disease, it should be considered as a life-saving operation for patients with MFS.

scholarly journals DIURETIC RESISTANCE IN ADVANCED HEART FAILURE: A Literature Review

2021 ◽  
Vol 2 (1) ◽  
pp. 8-15
Author(s):  
Anita Surya Santoso ◽  
Mohammad Saifur Rohman ◽  
Indra Prasetya ◽  
Budi Satrijo
Keyword(s):  
Heart Failure ◽  
Prognostic Factor ◽  
Literature Review ◽  
Cardiac Dysfunction ◽  
Signs And Symptoms ◽  
Underlying Mechanism ◽  
Advanced Heart Failure ◽  
Diuretic Resistance

Advanced heart failure (HF) is used to characterized patients in HF with severe symptoms, recurrent decompensation and severe cardiac dysfunction. The prevalencekof HFkis approximatelyg1-2% of thecadult population inhdeveloped countries and it will be rising more than 10%pamongapeoplec>70ayears of age, whereas estimated theoprevalence ofcpatients with advanced HF is about 1% until 10%cof thekoverallkHFopopulation. Most ofkthe HF hospitalizationssare due to signs and symptoms of fluidcoverload.Recurrent congestionccould worsen patientssoutcomes.Loopdiureticssare recommended for thectreatmentcofkcongestionqinprHF patient. cHowever,cdiureticvresistanceeispavcommon problem issueiinpacuteqdecompensationtofcadvancedochronicrheartwfailureq(ACHF) patients and established prognostic factor. Some early reports estimated the prevalence of diuretic resistance about 20%-30% in HF population. In this review, we will be discuss how to diagnose the advancedvheartufailurepand the underlying mechanism of diuretic resistancebin HF patients. We also describe pharmacologicalvand non-pharmacologicalstrategies to overcome this issue.

High-dose adenosine for refractory supraventricular tachycardia: a case report and literature review

2016 ◽  
Vol 27 (5) ◽  
pp. 981-984 ◽  
Author(s):  
Gal Dadi ◽  
Daniel Fink ◽  
Giora Weiser
Keyword(s):  
Heart Failure ◽  
Case Report ◽  
Literature Review ◽  
Cardiogenic Shock ◽  
Sinus Rhythm ◽  
Supraventricular Tachycardia ◽  
Electrical Cardioversion ◽  
High Dose ◽  
Prompt Treatment ◽  
Unstable Patient

AbstractSupraventricular tachycardia is the most common significant arrhythmia in children. If prolonged, it may cause heart failure and progress to cardiogenic shock warranting prompt treatment. The recommended interventions following vagal manoeuvres are intravenous adenosine and in the unstable patient electrical cardioversion. We present an infant with an unstable supraventricular tachycardia that was resistant to electrical cardioversion and recommended doses of adenosine. He reverted to sinus rhythm with a higher dose of adenosine, suggesting that such doses may be required in refractory supraventricular tachycardia.

Abstract P478: Trends in Concurrent Heart Failure and Acute Coronary Syndrome Hospitalizations: A Literature Review

Circulation ◽  
2020 ◽  
Vol 141 (Suppl_1) ◽  
Author(s):  
Sarah Godfrey ◽  
Laura Cohen ◽  
Susan Hennessy ◽  
Brandon Bellows
Keyword(s):  
Heart Failure ◽  
Acute Coronary Syndrome ◽  
Clinical Practice ◽  
Literature Review ◽  
Pooled Analysis ◽  
Coronary Syndrome ◽  
St Elevation ◽  
Recent Trends ◽  
Definition Of ◽  
Over Time

Purpose: Patients who present with concurrent heart failure (HF) and acute coronary syndrome (ACS) have an increased risk of mortality, but changes in clinical practice have improved clinical outcomes. We sought to examine recent trends in concurrent HF and ACS hospitalizations in the United States (US) through review of published literature. Methods: We searched the Medline and PubMed databases for studies published after January 1, 2000 reporting the hospitalizations for HF with concurrent acute coronary syndromes. We included studies performed in the US or with at least 25% US participants, that reported the proportion with concurrent HF and ACS, and used a clinical definition of HF (e.g. Killip Class II or III, NYHA Class, or Framingham Criteria). Studies were reviewed by and data was extracted using a standardized form. We extracted study and patient characteristics, definition of HF, and rates of concurrent HF and ACS hospitalizations. We categorized included studies by ACS type: (1) non-specific myocardial infarction (MI) or ACS, (2) non-ST elevation (NSTE) MI or NSTE-ACS, or (3) ST elevation (STE) MI. We descriptively examined recent trends in hospitalizations for concurrent HF and ACS over time; rates reported for multiple time periods or ACS types were considered separately. Results: We identified 23 observational studies, systematic reviews, and randomized clinical trials. Of these, we excluded 13 due to non-US populations, use of non-clinical definitions of HF (i.e., diagnosis codes), or not reporting rates of concurrent HF and ACS. Of the 10 included studies, 7 reported concurrent HF with non-specific MI or ACS from 1975 through 2005 across multiple registries and literature reviews. Rates ranged from 12.5% to 48.0% with no clear time-related trends. We identified 3 studies reporting concurrent HF with NSTEMI or NSTE-ACS from pooled analysis or the Global Registry of Acute Coronary Events (GRACE) registry from 1994 to 2008. Reported rates ranged from 8.2%-15.7% for studies starting in the 1990s with one study reporting and 6.1% in 2005. We identified 4 studies reporting concurrent HF with STEMI, including a pooled analysis, the GRACE registry, and a clinical trial. Rates of concurrent HF with STEMI appeared to decrease over time from 32.5% in 1990 to 1998, 15.6%-19.5% from 1999 to 2001, and 2.6%-11.0% in 2005. Conclusion: Our literature review found that there may be a decrease in concurrent HF and STEMI hospitalizations in recent decades, but no apparent trends with other types of ACS. This may be related to emphasis on early revascularization strategies, improved primary prevention, and/or earlier time to presentation due to increasing public awareness.. However, there was a dearth of data reporting concurrent HF and ACS hospitalization within the last decade. Further research is needed to understand the impact of multiple changes in clinical practice on secular trends.

Sign in / Sign up

Export Citation Format

Share Document